The use of buprenorphine/naloxone to treat borderline personality disorder: a case report

Brenna Hansen, Katelyn M. Inch, Brenna A. Kaschor

Open source

DOI: 10.1186/s40479-022-00181-1
Published: 2022-03-15
Container: Borderline Personality Disorder and Emotion Dysregulation
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40479-022-00181-1,
  title = {The use of buprenorphine/naloxone to treat borderline personality disorder: a case report},
  author = {Brenna Hansen and Katelyn M. Inch and Brenna A. Kaschor},
  year = {2022},
  journal = {Borderline Personality Disorder and Emotion Dysregulation},
  doi = {10.1186/s40479-022-00181-1},
  url = {https://doi.org/10.1186/s40479-022-00181-1}
}

RIS

TY  - JOUR
TI  - The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
AU  - Brenna Hansen
AU  - Katelyn M. Inch
AU  - Brenna A. Kaschor
PY  - 2022
JO  - Borderline Personality Disorder and Emotion Dysregulation
DO  - 10.1186/s40479-022-00181-1
UR  - https://doi.org/10.1186/s40479-022-00181-1
ER  -

APA

Hansen, B., Inch, K. M., & Kaschor, B. A. (2022). The use of buprenorphine/naloxone to treat borderline personality disorder: a case report. Borderline Personality Disorder and Emotion Dysregulation. https://doi.org/10.1186/s40479-022-00181-1

Source records

crossref · retrieved 2026-11-10T14:36:29.339Z